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Background:Mitochondrial diseases belong to the most severe inherited metabolic disorders affecting pediatric
population. Despite detailed knowledge of mtDNA mutations and progress in identiﬁcation of affected nuclear
genes, diagnostics of a substantial part of mitochondrial diseases relies on clinical symptoms and biochemical
data from muscle biopsies and cultured ﬁbroblasts.
Methods: To investigate manifestation of oxidative phosphorylation defects in isolated lymphocytes, digitonin-
permeabilized cells from 48 children were analyzed by high resolution respirometry, cytoﬂuorometric detection
of mitochondrial membrane potential and immunodetection of respiratory chain proteins with SDS and Blue
Native electrophoreses.
Results: Evaluation of individual respiratory complex activities, ATP synthesis, kinetic parameters of mitochondrial
respiratory chain and the content and subunit composition of respiratory chain complexes enabled detection of
inborn defects of respiratory complexes I, IV and V within 2 days. Low respiration with NADH-dependent
substrates and increased respiration with glycerol-3-phosphate revealed complex I defects; changes in p50 for
oxygen and elevated uncoupling control ratio pointed to complex IV deﬁciency due to SURF1 or SCO2mutation;
high oligomycin sensitivity of state 3-ADP respiration, upregulated mitochondrial membrane potential and low
content of complex V were found in lymphocytes with ATP synthase deﬁciency due to TMEM70mutations.
Conclusion: Based on our results, we propose the best biochemical parameters predictive for defects of respiratory
complexes I, IV and V manifesting in peripheral blood lymphocytes.
General signiﬁcance: The noninvasiveness, reliability and speed of an approach utilizing novel biochemical criteria
demonstrate the high potential of isolated lymphocytes for diagnostics of oxidative phosphorylation disorders in
pediatric patients.© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/3.0/).tial; AA, antimycin A; BNE, Blue
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Mitochondrial diseases belong to most severe inherited metabolic
diseases affecting pediatric population. They are caused by disorders
of mitochondrial biogenesis or by mutations in the structural subunits
of oxidative phosphorylation (OXPHOS) apparatus [1]. Genetics of
mitochondrial OXPHOS disorders is quite unique: they can be caused
either by mutations in nuclear genes or mutations in mitochondrial
DNA (mtDNA), which encodes 13 of ~90 OXPHOS structural subunits.
Mutations in the maternally-transmitted mtDNA are already well
characterized. Several hundreds of them have been described to date
(www.mitomap.com) and their detection and screening have become
rather routine task [2]. However, according to current estimates,
mtDNA mutations are responsible for only 25% of mitochondrial
diseases. The remainder originates from mutations in nuclear genes,the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
63P. Pecina et al. / BBA Clinical 2 (2014) 62–71and their diagnostics still poses a signiﬁcant challenge. Within the last
couple of years pathogenic mutations resulting in a mitochondrial
disease have been uncovered in ~110 nuclear genes [3] including
numerous novel factors of mitochondrial biogenesis (e.g. TMEM70 [4,
5], C12orf65 [6,7] C20orf7 [8], TACO1 [9], RMND1 [10], SDHAF1 [11],
SDHAF2 [12]). Nevertheless, most of the disease-causing genes from
the broad repertoire of more than thousand nuclear genes contributing
to the mitochondrial proteome (www.mitocarta.com [13]) still remain
to be identiﬁed. For example, among the very frequent defects of cyto-
chrome c oxidase — complex IV (cIV), the terminal enzyme complex
of the respiratory chain, the genetic basis underlying the disorder was
found in less than 50% of the cases [14].
Diagnostics of a substantial part ofmitochondrial diseases thus relies
on clinical symptoms and biochemical analyses. Assessment of ener-
getic function and content of individual mitochondrial proteins in pa-
tient tissues is mainly performed in bioptic samples of skeletal muscle
and/or cell cultures of skin ﬁbroblasts. Both approaches have signiﬁcant
drawbacks: muscle biopsy allows for an instant, single biochemical
analysis of the mitochondrial quantity and function, but it is often
complicated by muscle atrophy caused by mitochondrial disorders.
Due to its invasive nature, it is also often refused by the parents of the
patient, and the same holds true for the skin biopsy, necessary for es-
tablishing of ﬁbroblast cell culture. While the cell culture allows for
more systematic and repeated analysis of mitochondria, the diagnostic
results are only obtained after a prolonged period, ranging from several
weeks to months.
The analysis of mitochondrial energetic apparatus in peripheral
blood lymphocytes, with the help of sensitive functional methods and
detection of quantitative and qualitative changes in OXPHOS proteins,
could become an attainable alternativemethod. Although it is practical-
ly noninvasive and easily repeatable, functional and protein analyses of
mitochondrial OXPHOS system in lymphocytes or lymphoblasts have
only been used sporadically for the study of mitochondrial diseases
[15–25]. Even in this limited number of studies, lymphocytes were
more often used in monitoring of tissue speciﬁc presentation of respec-
tive mutations than as a primary diagnostic tool.
To establish this approach as an alternative diagnostic tool, we
adapted and optimized highly sensitive oxygraphy of digitonin-
permeabilized cells for analysis of the function of mitochondrial re-
spiratory chain in lymphocytes. Wherever feasible, we combined it
with the analysis of mitochondrial membrane potential (ΔΨm) by
cytoﬂuorometry and with protein analysis of OXPHOS complexes
by SDS-PAGE and BNE followed by speciﬁc immunodetection of
structural subunits of mitochondrial respiratory complexes. Subse-
quent statistical analysis uncovered reliable and selective markers
that can distinguish samples harboring deﬁciencies of complex I,
complex IV caused by SURF1 and SCO2 mutations, and complex V
on the basis of TMEM70 mutations.
2. Materials and methods
2.1. Patients
Peripheral blood samples (3–7 ml depending on patients' age) were
obtained from 48 children aged 1 month to 18 years. Out of them, 35
children with neurological disturbances and/or developmental delay
were referred by their local pediatricians for metabolic screening and
their parents agreed to take part in our study; seven children (P1, P4–
P5 and P7–P9) had already known mitochondrial disorder conﬁrmed
at biochemical and/or molecular level and six disease free children
served as the age-matched controls. Altogether, 37 children were ana-
lyzed once and eleven children were analyzed 2–3 times.
Mitochondrial patient P1 at the age of 11 years had severe ence-
phalopathy and arrest of anymental andmotor development due to de-
ﬁciency of respiratory chain complex I of unknown nuclear origin
without any mutation in the mtDNA. Patient P2 is a 13 years old girlwith intrauterine growth retardation and repeated attacks of cephalea
since the age of 6 years, dissociative psychiatric disease, progressive bi-
lateral deafness and progressive visual impairment with bilateral con-
centric visual ﬁeld loss. The parents did not approve of skin or muscle
biopsy. Molecular analyses from blood and buccal smear did not detect
any mtDNA mutation responsible for any of LHON, MELAS or MERRF
syndromes. Patient P3 was born at the 32nd week of gestation with a
birth weight of 1990 g and a length of 42 cm. Early postnatal adaptation
was uneventful, but he developed pharmaco-resistant seizures during
the third week of life. MRI of the brain revealed pachygyria and cortical
dysplasia. The lactic acidosis was not present. The boy died at the age of
4 months and autopsy revealed polymicrogyria focalis gyri temporalis
superioris l.sin. Patients P4 and P5 had progressive encephalopathy and
Leigh disease since the age of 10 and 12 months respectively due to de-
ﬁciency of respiratory chain complex IV and homozygous mutations in
SURF1 gene (c.845_846delCT and c.312_321del10insAT, respectively).
Patient P6 presented since the age of 7 months with failure to thrive, pro-
gressive encephalomyopathy andhypertrophic cardiomyopathy. The activ-
ity of complex IVwas low in lymphocytes and the consequentDNAanalysis
identiﬁed that the boy is compound heterozygote for mutations c.1ANG
and c.418GNA in SCO2 gene. Patients P7–P9 at the age of 17, 11 and
2.5 years have encephalocardiomyopathy with deﬁciency of respiratory
chain complex V due to homozygous c.317-2ANG mutation in TMEM70
gene (ﬁrst two of them were already described as P9 and P11 in [4]).
All work involving human samples was carried out in accordance
with the Declaration of Helsinki of the World Medical Association and
was approved by the Ethical Committees of the participating institu-
tions. The written informed consent was obtained from patients or pa-
tients' parents.
2.2. Lymphocytes
Within 1–2 h after collection, whole fraction of intact lymphocytes
was isolated from EDTA-blood by density medium centrifugation at
4 °C, using Ficoll-Paque PLUS (GE Healthcare Bio-Sciences) following a
standard protocol. Brieﬂy, blood sample was layered on top of an
equal volume of Ficoll and centrifuged at 800 g for 20 min. Separated
lymphocytes were carefully collected (~1 ml) and resuspended in
15 ml of erythrocyte lysing buffer (30 mM NH4Cl, 2 mM NH4HCO3,
20 μM Na2EDTA, pH 8) and incubated for 20 min on ice. Lymphocytes
were pelleted by 800 g centrifugation for 20 min, weighed and resus-
pended in PBS supplemented with protease inhibitors (1:500 protease
inhibitor cocktail, Sigma) for respiration measurements and SDS-PAGE
analysis. For BNE dry pellet of lymphocytes was used (see Section 2.4).
Protein concentration was determined by Bradford method [26] using
BSA as standard.
2.3. High resolution respirometry
Oxygen consumption was measured at 30 °C as described before
[27] using Oxygraph-2k (Oroboros). Freshly isolated lymphocytes
(0.6 mg protein) were suspended in 2 ml of KCl medium (80 mM KCl,
3 mMMgCl2, 1 mMEDTA, 5mM K-Pi, 10 mMTris–HCl pH 7.4) and dig-
itonin 0.05 g/g proteinwas used to permeabilize the plasmamembrane.
Formeasurements the following concentrations of substrates and inhib-
itors were used: 3 mM malate, 10 mM pyruvate, 10 mM glutamate,
10 mM succinate, 10 mM glycerol 3-phosphate (GP), 1 mM ADP, 5–
200 nM oligomycin, 150–200 nM FCCP, 0.25 μM antimycin A, 2 mM
ascorbate, 0.6 mM TMPD and 0.5 mM KCN. The oxygen consumption
was expressed in pmol oxygen/s/mg protein.
p50 value – the partial oxygen pressure (pO2), at which the cellu-
lar respiratory rate is half-maximal –was determined as before [28].
Brieﬂy, the volume-speciﬁc rate of oxygen consumption (oxygen
ﬂux) was calculated as the negative slope of oxygen concentration
recorded at 1 s time intervals. The signal was deconvoluted with
the exponential time constant of the oxygen sensor (3 to 5 s) and
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experimental pO2 and results from oxygen consumption by the sen-
sor and oxygen back-diffusion from low capacity oxygen reservoirs.
The p50 parameter was obtained from a hyperbolic function J02 =
(Jmax · pO2) / (p50 + pO2) ﬁtted over the low oxygen range of 0 to
1.1 kPa. All calculations were performed using routine functions of
the DatLab software [29].
2.4. Electrophoresis, western blot analysis, in-gel activity assays
Tricine SDS-PAGE [30] was performed on 10% polyacrylamide
minigels (MiniProtean III system, BioRad). Pelleted aliquots of isolated
lymphocytes (0.1 mg protein) were resuspended in sample buffer (2%
(v/v) mercaptoethanol, 4% (w/v) SDS, 50 mM Tris–HCl, pH 7.0, 10%
(v/v) glycerol) using 10 × 0.5 s sonication pulses and immediately
denatured at 100 °C for 10 min.
Blue Native PAGE (BNE) [31] was performed on 5–13% gradient
polyacrylamide slab minigels. Pelleted lymphocytes (0.25 mg protein)
were homogenized in 0.5 ml of KCl medium supplemented with prote-
ase inhibitors using a teﬂon-glass homogenizer (30 × 500 rpm) and
centrifuged 20,000 g for 10 min at 4 °C. The sediment was resuspended
in solubilization buffer (50 mM NaCl, 50 mM imidazole, 2 mM 6-
aminohexanoic acid and 1 mM EDTA, pH 7), incubated with n-dodecyl
β-D-maltoside (DDM) for 15 min on ice (2.5 g/g protein) and centri-
fuged at 30,000 g for 20 min. The protein concentration in the superna-
tant was determined and samples were prepared by adding 5% (v/v)
glycerol and Serva Blue G 250 (0.6 g/g of DDM).
For western blot analysis, gels were blotted onto a PVDF mem-
brane (Immobilon P, Millipore) by semidry electrotransfer for 1 h
at 0.8 mA/cm2. The membranes were blocked in TBS (0.15 M NaCl,
10 mM Tris–HCl, pH 7.5) with 0.1% (v/v) Tween-20 and 5% (w/v)
non-fat dry milk. Membranes were incubated overnight with anti-
body cocktail (MS603, Abcam, 1:250), which included antibodies
against the following OXPHOS subunits: Ndufa9 (complex I), Sdha
(complex II), Uqcrc2 (complex III), Cox4 (complex IV), Atp5a1 (com-
plex V) or with antibodies against individual OXPHOS subunits,
when indicated. The membranes were then incubated for 1 h with
appropriate secondary antibody labeled with Alexa Fluor 680 (Life
Technologies, 1:3,000). The ﬂuorescence was detected using Odys-
sey Imager (Li-Cor) and the signal was quantiﬁed using Aida 3.21
Image Analyzer software (Raytest).
2.5. Cytoﬂuorometric analysis of mitochondrial membrane potential
Measurements of ΔΨm according to Ref. [32] were adapted to
lymphocytes and performed on a PAS III cytoﬂuorometer (Partec).
Cells were suspended to 1 mg protein/ml in a KCl based medium
(120 mM KCl, 3 mM HEPES, 5 mM KH2PO4, 3 mM MgSO4, 1 mM
EGTA, pH 7.2), permeabilized by 0.1 mg/ml digitonin (0.1 g/g pro-
tein), diluted to 20 μg/ml and incubated with 10 mM succinate and
20 nM tetramethylrhodamine methyl ester (TMRM, Life Technolo-
gies) for 10min. ADP (1mM) or FCCP (1 μM)was added 1min before
cytoﬂuorometric analysis. 10 000 cells were used for each measure-
ment. Data were acquired on a log scale and subsequently analyzed
using FloMax software (Partec). TMRM ﬂuorescence changes were
calculated as percent differences between log(10) values of mean
ﬂuorescence signals. Difference between s4 and s3u was considered
to be 100%.
3. Results
3.1. General outline of lymphocyte mitodiagnostics
Fig. 1 summarizes the workﬂow of our diagnostic approach using
isolated lymphocytes. Based on the detailed analysis of 60 lymphocyte
preparations, obtained from 48 pediatric patients aged ~1m–18y(b6m 18x, 6m–1y 9x, 1y–5y 19x, 5y–10y 5x, 10y–18y 9x), a 7 ml
blood aliquotwas sufﬁcient to yield 20-50mg (wetweight) ofmononu-
clear cells. Cells were subsequently resuspended in PBS (~100 μl/50 mg
wet weight) with protease inhibitors to yield a lymphocyte suspension
with protein concentration ~10 mg/ml. The average yield of isolations
was 1126 μg protein of isolated lymphocytes, corresponding to 158 μg
protein of lymphocytes obtained from 1 ml of blood. The amounts of
protein required for individual analytical approaches were ~600 μg pro-
tein for oxygraphy, ~150 μg protein for cytoﬂuorometric analysis,
~100 μg protein for SDS-PAGE/WB, and ~250 μg protein for native
PAGE/WBperformed as described in theMaterials andmethods section.
Therefore, in most cases a complete mitodiagnostics can be performed
with lymphocytes obtained from one aliquot of peripheral blood.
3.2. Respiration measurements
We set to design experimental workﬂow for respiration measure-
ment, which will allow analysis of activities of intact respiratory chain
and its individual complexes at coupled and uncoupled states, sensitiv-
ity to key inhibitors aswell as afﬁnity to oxygen. Overview of such assay
is given in Fig. 2. Upon permeabilization of cells with digitonin, the
addition of pyruvate and malate followed by ADP provides the mea-
sure of pyruvate dehydrogenase (PDH) and cI-dependent respiration
at state 3-ADP (s3); the subsequent addition of alternative NADH-
generating substrate glutamate would reveal a PDH defect, as it is ca-
pable of fully saturating complex I. Subsequent separate additions of
succinate and glycerol-3-phosphate (GP) are used to assay the con-
tributions of succinate dehydrogenase (SDH, cII) and GPDH to the
maximum respiratory chain electron ﬂux coupled to ATP synthesis
achieved only after combination of these substrates. Titration with
the ATP synthase inhibitor oligomycin provides the I50 value indica-
tive of the amount of functional ATP synthase (complex V, cV) pres-
ent in lymphocyte mitochondria and proton leak-driven state 4
respiration (s4o) is achieved after a complete inhibition of cV. State
3-uncoupled respiration (s3u) – a measure of electron transport
chain capacity – is obtained by FCCP titration, the maximal rate
being achieved in the 150–200 nM concentration range of the uncou-
pler. To assess the p50 value of oxygen consumption indicative of the
afﬁnity of cytochrome c oxidase (cIV) to oxygen, respiration is
allowed to proceed until all oxygen is consumed. After reoxygena-
tion the respiratory chain is blocked at the level of bc1 complex
(cIII) by addition of antimycin A, and activity of cIV is assessed by
ascorbate and TMPD, followed by addition of KCN that speciﬁcally in-
hibits cIV and provides the rate of cIV independent autooxidation of
the artiﬁcial cIV substrates.
3.3. Reference charts of respiratory activities in isolated lymphocytes
Fig. 3A summarizes the statistical analysis of respiration rates ob-
served in isolated lymphocytes according to protocol in Fig. 2, namely
state 3-ADP (s3) respiration with different substrates (cI s3, cI + cII s3,
cI + cII + GPDH s3), oligomycin-induced state 4 (s4o) respiration
with all substrates (cI + cII + GPDH s4o), FCCP-induced uncoupled
(s3u) respiration with all substrates (cI + cII + GPDH s3u) and
uncoupled respiration of cIV only (COX). The box plots show the mini-
mum, 1st quartile median, 3rd quartile, andmaximum values of speciﬁc
rates of respiration calculated in pmol oxygen consumed/s/mg protein.
The overall statistical analysis reveals that only the combination of elec-
tron input from complexes I, II, and GPDH is able to fully saturate the
downstream components of the respiratory chain. Similar rates of s3
and s3u respiration indicate that the capacities of electron transport
chain and the enzymes involved in ADP phosphorylation seem to be
wellmatched. Also, the activity of cIV does not seem to be in huge excess
over the upstream components of respiratory chain as is frequently ob-
served in other cell types or mitochondria isolated from tissue samples.
Fig. 1. Flow chart of mitochondrial oxidative phosphorylation system (OXPHOS) analysis in isolated lymphocytes.
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respiratory rates, typically 3 to 4-fold differences between the minimal
and maximal values in each state. Using these primary data, the follow-
ing functional parameters of respiratory chain essential for evaluation of
suspected OXPHOS disorders were calculated: respiratory control ratio
calculated from ADP-stimulated or uncoupler-stimulated respiration
(RCRADP, RCRFCCP) indicating how tightly coupled is mitochondrial
OXPHOS, relative activities of state 3 ADP-coupled respiration via indi-
vidual dehydrogenases indicating the capacities of these dehydroge-
nases (cI, cII and GPDH), sensitivity to oligomycin indicating capacity
of ATP synthase to phosphorylate ADP, state 4 after oligomycin inhibi-
tion indicating the proton leak of the inner mitochondrial membrane,
state 3 uncoupled respiration indicating maximum capacity of electronFig. 2. Substrate-inhibitor respiratory measurements using isolated lymphocytes. Complex
protein.ml−1 + permeabilizing agent digitonin at 0.05 mg per mg of protein; 2 — Malate 3
1 mM, phosphorylation substrate for ATP synthase, activates respiration by utilizing ΔΨm; 4—
by complex II, additional electron input into respiratory chain; 6 — Glycerol 3-phosphate 10 m
spiratory state 3 (s3); 7— Oligomycin, ATP synthase inhibitor, sensitive assessment of enzyme
(red ellipse), respiratory state 4 oligomycin (s4o); 8— FCCP, uncoupler, achievement ofmaxim
low ellipse); 9— Full depletion of oxygen— calculation of oxygen kinetics (p50), followed by reox
Ascorbate 2mM+TMPD 0.6mM, artiﬁcial substrates feeding electrons directly to cytochrome c/c
tion due to ascorbate + TMPD autooxidation.ﬂow via respiratory chain, p50 oxygen value indicating cIV afﬁnity to
substrate — oxygen, and ﬁnally the activity of cIV. To evaluate how the
electron transport chain activity exceeds the ADP phosphorylating
activity the uncoupling control ratio (UCR) was calculated as the ratio
between s3u and s3 oxidation of all substrates (cI + cII + GPDH s3u/
cI + cII + GPDH s3).
Based on these data it should be possible to identify several types
of mitochondrial disorders resulting from insufﬁcient function of
the respiratory chain at the level of individual respiratory chain
complexes and ATP synthase as well as to indicate corresponding
dysfunction in PDH and other components of ATP synthasome phos-
phorylating assembly, adenine nucleotide translocator and phos-
phate translocator.analysis of respiratory chain functions includes the following steps: 1 — Cells at 0.3 mg
mM + pyruvate 10 mM, substrates generating NADH oxidized by complex I; 3 — ADP
Glutamate 10 mM, additional substrate generating NADH; 5— Succinate 10mM, oxidized
M, oxidized by GPDH, additional electron input into respiratory chain Maximal rate at re-
capacity by step titration in 5, 10, 20, 40, 60, 80, 120, 160 and 200 nM ﬁnal concentration
al respiratory rate at state 3 uncoupled (s3u) by step titration, usually at 150–200 nM (yel-
ygenation of medium (blue ellipse); 10— Antimycin A 0.25 μM, complex III inhibition; 11—
omplex IV; 12— KCN 0.5mM— inhibition of complex IV, KCN insensitive oxygen consump-
Fig. 3. Respiratory rates and respiratory control indexes in isolated lymphocytes. Statistical analysis of data from lymphocytes of 48 children includes controls as well as patients with
mitochondrial disorders. (A) Absolute respiratory rates. The following abbreviations are used — cI, cII, cIV, respiratory complexes I, II, IV GPDH, mitochondrial glycerophosphate
dehydrogenase s3 respiration at state 3-ADP s3u, respiration at state 3-uncoupled s4o, respiration at state 4 oligomycin. (B) Respiratory control ratios (RCR). Box plots represent Q1,
median, Q3 (box), and minimum and maximum (whiskers), asterisks denote means.
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The oxygen consumption trace of lymphocytes from patient P3
represents a typical case where cI deﬁciency has to be considered
(Fig. 4A). Low respiration with cI substrates (malate + pyruvate +
glutamate) is clearly apparent, while respiration with ﬂavoprotein-
dependent substrates succinate and GP is normal or even increased.
Based on the statistical analysis of all measurements performed, we
identiﬁed three patients (P1–P3) with suspected mitochondrial dis-
order that showed low values of relative contribution of cI-dependent
respiration to the s3 rate with all substrates (Fig. 4B). The mean values
of the relative respiration rates for patients and controls are shown in
Table 1.
Moreover, a substantially elevated GPDH-dependent respiration ac-
companied the decreased oxidation of substrates for cI in these samples.Fig. 4. Complex I deﬁcient lymphocytes. (A) Decreased function of complex I in patient P3 lym
the experimental traces represent the relative portion (%) of maximal state 3 respiration con
contribution of complex I to the maximum rate of state 3-ADP respiration. Box plots repre
means, n = 60. (C) Scatter plot showing negative correlation between cI-speciﬁc and GPDH-s
cI disorders. Values of patients P1–P3 are marked by red circle.As depicted in Fig. 4C, analysis of all measurements performed in 60
lymphocyte preparations revealed that there is indeed a negative
correlation between these parameters, i.e. between the cI-portion and
GPDH-portion of the maximum state 3-ADP respiration observed with
cI + cII + GPDH substrates. Interestingly, patients with low cI activity
also showed the highest ratio between GPDH-dependent and
cI-dependent respiration activities. Therefore, the simultaneous evalua-
tion of cI- and GPDH-dependent portions of s3 respiration provides a
sensitive measure to uncover cI defects.
3.5. Complex IV deﬁciency
The nuclear genetic defects are rather frequent cause of cytochrome
c oxidase disorders [14]. Probably the most common among them are
mutations in SURF1 gene encoding cIV-speciﬁc assembly factor [33,phocytes detected as low respiration with NADH-dependent substrates. The ﬁgures above
tributed by individual dehydrogenases. (B) Statistical presentation of decreased relative
sent Q1, median, Q3 (box), and minimum and maximum (whiskers), asterisks denote
peciﬁc respiration (n = 60), highest ratio of these parameters indicates to the suspected
Table 1
Diagnostic parameters for cI, cIV and cV disorders in isolated lymphocytes.
Parameter Patients Controls p
Complex I deﬁciency (n = 5)
cI-dependent respiration 0.21 ± 0.070 0.43 ± 0.067 b0.01
cII-dependent respiration 0.35 ± 0.055 0.39 ± 0.063 n.s.
GPDH-dependent respiration 0.43 ± 0.050 0.17 ± 0.014 b0.001
cI/GPDH 0.51 ± 0.231 2.61 ± 0.485 b0.001
Complex IV deﬁciency (n = 3)
UCR 1.57 ± 0.113 1.13 ± 0.091 b0.01
p50 (kPa) 0.083 ± 0.0119 0.025 ± 0.0031 b0.001
cIV cox4/cII SDHA content (AU/AU) 0.31 ± 0.094 1.24 ± 0.288 b0.05
Complex V deﬁciency (n = 6)e
Inhibition of state 3 respiration by
20 nM oligomycin (in %)
36.5 ± 29.17 7.2 ± 1.36 b0.05
UCR 1.57 ± 0.192 1.13 ± 0.091 b0.01
ADP-induced decrease of ΔΨm (in %) 21.52 ± 0.85 53.73 ± 2.99 b0.001
cVα/cII SDHA content (AU/AU) 0.32 ± 0.053 0.78 ± 0.025 b0.01
Analysis of respiratory parameters and western blot detection of indicated respiratory
complexes was performed as described in the Materials and methods section. cI-, cII-
and GPDH-dependent respirations are expressed relative to overall cI + cII + GPDH
state 3 respiration. Inhibition by oligomycin is expressed in % of the overall oligomycin-
sensitive cI + cII + GPDH state 3 respiration. ADP-induced decrease of mitochondrial
membrane potential ΔΨm at state 4-succinate (in %). Values represent mean ± SD of
ﬁve independent controls. P1, P4, P5, P6, and P7 lymphocytes were isolated and analyzed
once; P2, P3, and P8 twice; and P9 thrice, to give the total number of measurements as
indicated for each patient group in the table. p represents the probability of t-test analysis
used to assess the statistical signiﬁcance.
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decreased content of COX which is structurally and functionally altered
[27,28,35]. Patients typically present with fatal Leigh syndrome and cIV
in ﬁbroblasts reveals a decreased proton pumping activity and de-
creased afﬁnity to oxygen while the electron transport activity of cIV
is generally unaffected. Fig. 5 summarizes the analysis of lymphocytes
from two 2 years old patients (P4, P5), harboring SURF1 mutations
and from another 7 months old patient (P6) with encephalomyopathy
and hypertrophic cardiomyopathy. Subsequent DNA analysis of this
patient identiﬁed mutation in SCO2, another cIV assembly factor, as a
genetic cause of observed cIV deﬁciency.
On an absolute scale, these lymphocytes displayed normal values of
cI + cII + GPDH s3, cI + cII + GPDH s3u as well as COX activity. Only
when related to the rate of s3u respiration, COX-dependent oxygen con-
sumption was mildly decreased in one of the patients (not shown).
However, in all three patients the p50 values for oxygen were increasedFig. 5. Detection of complex IV defects in lymphocytes. (A) Oxygen p50 value (n = 47) and (
decrease of cIV (subunit cox4) in comparison to normal content of cI (NDUFA9 subunit), cII (
patients P4 and P5 harboring SURF1mutations (red arrows) and P6 patient harboring SCO2m
content of cIV (n = 28) is shown. Box plots represent Q1, median, Q3 (box), and minimum anto more than 3-times of the median value, and actually represented the
highest values among all lymphocyte measurements performed
(Fig. 5A). Besides reﬂecting COX Km to oxygen, the p50 value also nega-
tively correlates with the cIV relative content to upstream respiratory
chain components [36]. Western blot analysis revealed pronounced
decrease in the content of subunit 4 (cox4) of cIV in P4–P6 (Fig. 5C)
and when the p50 was related to the cIV content, most extreme values
of both parameters (Fig. 5D) found in lymphocytes harboring SURF1
and SCO2 mutations were indicative for conﬁdent diagnosis of
cIV defect. Moreover, the ratio between cI + cII + GPDH s3u
and cI + cII + GPDH s3 respiration — the uncoupling control ratio
(UCR) was elevated (Fig. 5B) in P4–P6 lymphocytes, indicating that
electron transport activity exceeds the ADP phosphorylation capacity
of OXPHOS in these cells. The mean values of parameters shown in
Fig. 5 for patients and controls are shown in Table 1.3.6. Complex V deﬁciency
The third type of mitochondrial disorder that we have analyzed in
isolated lymphocytes was ATP synthase deﬁciency due to mutations in
TMEM70 gene, manifesting as neonatal encephalocardiomyopathy [4,
37]. Fig. 6 summarizes the analysis of lymphocytes from 3 patients
with TMEM70 mutations (P7–P9). The low content of ATP synthase in
these cases limits the phosphorylating capacity of mitochondrial
OXPHOS system. This was primarily observed as increased sensitivity
to oligomycin, speciﬁc inhibitor of ATP synthase\ a signiﬁcant decrease
of coupled respiration was observed at a much lower titer of the inhib-
itor (Fig. 6A). Statistically, this parameter appears to be particularly
valuable for diagnostic purposes, as lymphocytes harboring TMEM70
mutations represent the most outlying data points in the box plots
displaying the residual oligomycin-sensitive portion of s3 respiration,
most apparently at 10 and 20 nM concentrations of the inhibitor. More-
over, the low content of ATP synthase limits the cI + cII + GPDH s3 re-
spiratory rate relative to state s3u, as evidenced by increased values of
UCR (Fig. 6B). In permeabilized lymphocytes with TMEM70 mutation
we have also performed measurements of mitochondrial membrane
potential (ΔΨm) by cytoﬂuorometric analysis following changes in the
ﬂuorescence of cationic probe TMRM (Fig. 6C). In patient lymphocytes
supplemented with succinate we have observed a much smaller
decrease of ΔΨm upon addition of ADP, compared to a pronounced
decrease of ΔΨm in control lymphocytes (21% versus 51% decrease of
the state 4 value), indicating that the low content of ATP synthase
limits the discharge of respiration-generated proton gradient byB) the uncoupling control ratio (n = 60) are increased in lymphocytes with (C) isolated
SDHA subunit), cIII (core2 subunit) and cV (α subunit) detected by SDS-PAGE/WB from
utation (blue arrows), respectively; in (D) the elevated ratio of oxygen p50 relative to the
d maximum (whiskers), asterisks denote means.
Fig. 6. Detection of ATP synthase deﬁciency in lymphocytes. (A) Sensitivity of state 3-ADP respiration (with glutamate + malate + succinate + glycerol-3-phosphate) to oligomycin is
increased (n = 50, box plots represent Q1, median, Q3 (box), minimum and maximum (whiskers), asterisks denote means) and (B) uncoupling control ratio (n = 60) is elevated in
lymphocytes from patients (P7–P9) with ATP synthase deﬁciency due to TMEM70mutation (data points of TMEM70 patients are marked by red circles). (C) High levels of mitochondrial
membrane potentialΔΨm at state 3-ADP detected by TMRM (20 nM) cytoﬂuorometry (analysis was performed using 10mM succinate (state 4o), after addition of 1mMADP (state 3) or
1 μMFCCP (state 3u), decrease inΔΨm is expressed as % change fromstate 4 value). (D) diminished content of ATP synthase complex (cV) in comparison to the content of other respiratory
chain complexes detected by BNE/WB and by (E) SDS-PAGE/WB using subunit speciﬁc antibodies to cV (α subunit), cI (NDUFA9 subunit), cII (SDHA subunit), cIII (core2 subunit) and cIV
(cox4 subunit), P — P7, C — control.
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ATP synthase in lymphocytes was detected by native electrophoresis in
combination with immunodetection. As seen in Fig. 6D, ATP synthase
complex of 600 kDa was almost undetectable in patient lymphocytes
with TMEM70 mutation. Corresponding speciﬁc decrease of α subunit
of cV was found by SDS electrophoresis and WB, while the levels of cI,
cII, cIII and cIVwere unaffected (Fig. 6E). Themean values of respiration
inhibition at 20 nMoligomycin, UCR, ADP-induced decrease ofΔΨm and
cV α subunit content for patients and controls are shown in Table 1.
4. Discussion
Mitochondrial diseases are responsible for a signiﬁcant portion of
mortality and morbidity in the youngest groups of children. Due to the
frequent impairment of brain function, the surviving patients represent
a serious socioeconomic problem. As there is no causal therapy available
for most mitochondrial diseases, the early diagnosis of biochemical and
genetic defects is of utmost importance for prevention and genetic
counseling in affected families.
In the present study we focused on establishing of noninvasive
diagnostic methods for fast and precise identiﬁcation of mitochondrialdysfunction and elucidation of molecular basis of their phenotypic
manifestation. We demonstrate that the important improvement in
timely diagnostics of mitochondrial disorders of OXPHOS system can
be achieved by the use of lymphocytes isolated from peripheral blood.
The analysis of mitochondrial functions was based on adaptation of
protocols developed for mitochondrial diagnostics in cultured skin
ﬁbroblasts [25,27,28,32]. The key method is the oxygraphic analysis of
mitochondrial energetics in digitonin-permeabilized lymphocytes by a
complex substrate-inhibitor approach which provides detailed in-
formation about electron transport activities of respiratory chain com-
plexes, ATP synthesis as well as respiratory control, ATP synthase
function or complex IV afﬁnity to oxygen.Where feasible, the measure-
ments can be complemented by the cytoﬂuorometric detection of ΔΨm
with TMRM. The functional analysis is further accompanied by analysis
of respiratory chain protein complexes and their subunits by electro-
phoretic methods utilizing native and SDS electrophoreses in combina-
tion with western blot immunodetection.
Altogether, we have analyzed 60 samples of lymphocytes from chil-
dren with suspected mitochondrial disorders, children with previously
diagnosed OXPHOS disorders as well as children with normal function
ofmitochondrial OXPHOS system. Statistical analysis of allmeasurements
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ering the normal control values and their ﬂuctuation aswell as the outly-
ing pathological values indicative of possible OXPHOS dysfunction.
Rather than comparing a given casewith selected control samples, we fo-
cused on the analysis of statistically extreme values in one or several pa-
rameters that are indicative for a certain OXPHOS disorder. This approach
enabled us to select the best diagnostic markers for individual OXPHOS
defects based on the whole dataset, without the requirement for their a
priori deﬁnition. The signiﬁcance of these parameters with respect to
controls is summarized in Table 1. Our results indicate that this type of
analysis is sensitive enough to recognize several types of OXPHOS
deﬁciencies, namely isolated defects of complex I, complex IV and
ATP synthase when they are manifested in lymphocytes.
The analysis of lymphocytes revealed a low activity of cI in three pa-
tients, P1–P3. In the ﬁrst patient with severe encephalopathy, the low
activity of cI was conﬁrmed in ﬁbroblasts but the genetic defect remains
unknown— nomutation inmtDNAwas found and the search for nucle-
ar genes responsible for complex I deﬁciency by exome sequencing has
not yet been completed. Amarked decrease of cI activity was also found
in patient P2, where the mitochondrial impairment was indicated by
progressive sensorial defects and cephalea attacks. In the third case,
P3 who died at 4 monthswith a pronounced brain impairment, the res-
pirometry revealed cI deﬁciency in lymphocytes, while spectrophoto-
metric analyses in cultivated ﬁbroblasts showed a normal activity and
amount of respiratory chain complexes. The muscle biopsy was not
available. The mitoanalysis of lymphocytes could thus indicate a tissue
speciﬁc type of disorder of respiratory chain complex I.
Importantly, in all three patientswith low electron transport activity
of cI we have found that besides decreased values of state 3-ADP
respiration with cI-dependent substrates, they have consistently up-
regulated GP-supported respiration. We therefore propose that the
increased GPDH-sensitive portion of the maximum respiration of cI +
cII + GPDH substrates, as well as high ratio of GPDH-dependent/cI
dependent respiration may serve as sensitive diagnostic criteria for cI
dysfunction. Such an increase of GP respiration likely results from in-
creased relative contribution to overall ﬂux capacity of the respiratory
chain [38,39] when electron transport from cI is decreased. Alternative-
ly it may reﬂect an adaptive increase of mitochondrial content of FAD-
dependent GPDH. Together with cytosolic NAD-dependent GPDH,
they constitute glycerophosphate shuttle which facilitates oxidation of
cytosolic NADH and thus bypasses respiratory complex I [40].
The activity of cIV has to be signiﬁcantly affected to inﬂuence respi-
ration with different substrates due to excess capacity of COX in most
mammalian cells and tissues [39]. Thus direct measurement of cIV
activity, as respiration with artiﬁcial substrates ascorbate + TMPD in
the presence of antimycin A, may detect the change in cIV electron
transport activity more sensitively than when it is only slightly de-
creased. Such a situation is expected in patients with cIV dysfunction
due to SURF1mutations and our measurements showed that this also
holds true in lymphocytes from these patients. However, we showed
that the increase of p50 value ismuchmore sensitive parameter for diag-
nostics of this type of cIV disorder. P50 serves as themeasure of the afﬁn-
ity of respiration towards oxygen, and the observed changes in
lymphocytes are in accordance with data previously observed in ﬁbro-
blasts with SURF1mutations [28]. In addition, SURF1 protein-deﬁcient
lymphocytes also displayed a high value of UCR (N90th percentile)
which is in agreement with our previous observation that in patient ﬁ-
broblasts s3 respiration is decreased more signiﬁcantly than s3u respi-
ration [27].
Another important ﬁnding of our study is that all these changes,
which are indicative for COX deﬁciency, could also be found in lympho-
cytes of the patient with SCO2 mutation. COX deﬁciency due to SCO2
dysfunction does not manifest in ﬁbroblasts [41,42] and thus analysis
of lymphocytes may serve as an preferred diagnostic approach.
The third type of mitochondrial disorder that we have detected in
isolated lymphocytes was ATP synthase deﬁciency, due to TMEM70mutations, a very frequent type of autosomal recessive deﬁciency of
ATP synthase [43]. In this case, several parameters can be used for iden-
tiﬁcation of ATP synthase dysfunction in lymphocytes, namely in-
creased sensitivity of state 3-ADP respiration to oligomycin and
decreased rate of state 3-ADP respiration relative to state 3-uncoupled
respiration. The low content of cV is further detected by electrophoretic
analysis and the third independent approach can be cytoﬂuorometric
analysis of mitochondrial membrane potential, which shows elevated
values of ΔΨm at state 3-ADP. Importantly all these changes have pre-
viously been found in patient ﬁbroblasts with TMEM70mutations [4,5].
More than two decades passed since the ﬁrst attempts to use blood
cells, in particular lymphocytes for studying of inherited mitochondrial
disorders [15–18]. In subsequent years oxygraphy in combination with
spectrophotometric measurements proved useful to identify different
types of OXPHOS defects, mainly those caused by mtDNA mutations
[19–25]. However, these approaches never became prominent tool for
primary diagnostics. Today, isolated lymphocytes or lymphoblasts are
only rarely utilized for routine biochemical analysis of mitochondrial
respiratory chain function in patients with suspected inborn defects in
oxidative phosphorylation. In part, this may reﬂect potential issues
regarding tissue speciﬁcity of disease presentation as well as varying
heteroplasmy load between tissues in case of mtDNA mutations [44–
49]. Methodical limitations in early studies, which usually focused
only on a defect in the particular OXPHOS complex, as well as limited
yield and viability period of intact isolated lymphocyte cells were possi-
bly other confounding factors leading to the limited use of lymphocytes.
It should be stressed out however, that in the last couple of years, pe-
ripheral blood cells came into focus of researchers looking for disease
biomarkers, primarily due to their easy accessibility. Peripheral blood
cells in general or their respective subpopulations were used for evalu-
ation of mitochondrial functions in a wide range of human pathologies
[50].While some of the pathologies studied are systemic, such as diabe-
tes [51] and septic shock [52], others e.g. neurodegenerative diseases
[53,54], glaucoma [55] or ﬁbromyalgia [56] display tissue speciﬁcity in
their symptoms and yet manifest as mitochondrial dysfunction in pe-
ripheral blood cells. In many respects this represents analogous situa-
tion to inherited mitochondrial diseases.
Our studies clearly demonstrated that by combined approach in-
volving sensitive functional methods (oxygraphy and cytoﬂuorometry)
and protein analysis by electrophoretic methods andwestern blotting it
is possible to detect several types of isolatedOXPHOSdisorders of nucle-
ar genetic origin. These are: (i) low respirationwith cI substrates and in-
creased respiration with GP revealed decreased activity of respiratory
chain complex I, (ii) changes in p50 for oxygen and high value of UCR
pointed to COX deﬁciency due to SURF1mutations and (iii) high sensi-
tivity to oligomycin, upregulated mitochondrial membrane potential
and low content of ATP synthase complex were found in lymphocytes
with ATP synthase deﬁciency due to TMEM70mutations. Based on our
current experience further systematic investigations of lymphocytes
will be performed to evaluate the potential of this type of mitoanalysis
for diagnostics of a broader range of mitochondrial disorders. Detection
of other defects (e.g. PDH deﬁciency by low cI dependent respiration
with pyruvate compared to glutamate plus malate) using the same
experimental protocol can be envisaged but remains to be validated
on respective patients.
Mitodiagnostics in isolated lymphocytes described herein represent
fast and technically affordable approach. The oxygraphic analysis and
mitochondrial membrane potential analysis are performed on freshly
isolated lymphocytes and are completed within a day. Electrophoretic
analysis in combination with immunodetection does not require fresh
material and can be completed in 2 days. The key approach is the high
resolution respirationmeasurements using Oxygraph 2k, which is sufﬁ-
ciently sensitive andwell suited for a complex, substrate-inhibitormea-
surements in permeabilized lymphocytes. One such measurement
usually lasts for ~2 h. The detailed evaluation of these measurements
is subsequently performed by the data analysis using DatLab software.
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well-established method that provides relative values of ΔΨm, rather
than exact values inmV. Nevertheless, it represents a sensitive approach
to detect differences between patient and control in the key parameters
ofΔΨm. By detecting energization of the innermitochondrial membrane
at state 4 and state 3we can get insight into the function of ATP synthase.
The two electrophoretic methods used (SDS-PAGE and native-PAGE)
represent routine tools for determination of the amount, subunit compo-
sition as well as native forms of all mitochondrial OXPHOS complexes
visualized by immunodetection with commercially available, subunit
speciﬁc antibodies. For quantitative analysis the detection using ﬂuores-
cent secondary antibodies and laser scanners is a method of choice.
In conclusion, our study demonstrates that the use of isolated lym-
phocytes obtained from peripheral blood in combination with analysis
of mitochondrial functions and quantitative/qualitative analysis of mito-
chondrial OXPHOS complexes represents a sensitive, fast and noninva-
sive approach for rapid screening and diagnostics of different types of
mitochondrial disorders, especially of nuclear genetic origin manifesting
in pediatric patients. In addition, repeated analyses of lymphocytes offer
a possibility to follow the changes in mitochondrial energetic system in
the course of the disease progression.
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